Provided by Tiger Trade Technology Pte. Ltd.

Bruker

38.94
-0.5400-1.37%
Post-market: 38.940.00000.00%18:51 EDT
Volume:1.51M
Turnover:59.07M
Market Cap:5.92B
PE:-259.60
High:39.71
Open:39.48
Low:38.67
Close:39.48
52wk High:56.22
52wk Low:28.53
Shares:151.94M
Float Shares:103.15M
Volume Ratio:0.99
T/O Rate:1.47%
Dividend:0.20
Dividend Rate:0.51%
EPS(TTM):-0.1500
EPS(LYR):-0.1500
ROE:-0.38%
ROA:2.90%
PB:2.41
PE(LYR):-259.60

Loading ...

Bruker Nano Inc. EVP and President Mark Munch Disposes of Bruker Corporation Common Shares

Reuters
·
Feb 19

These Analysts Cut Their Forecasts On Bruker Following Q4 Results

Benzinga
·
Feb 14

UBS Adjusts Price Target on Bruker to $40 From $43, Maintains Neutral Rating

MT Newswires Live
·
Feb 14

Bruker Is Maintained at Overweight by Barclays

Dow Jones
·
Feb 13

Stifel Nicolaus Reaffirms Their Hold Rating on Bruker (BRKR)

TIPRANKS
·
Feb 13

Bruker price target raised to $49 from $43 at UBS

TIPRANKS
·
Feb 13

Guggenheim Keeps Their Buy Rating on Bruker (BRKR)

TIPRANKS
·
Feb 13

U.S. RESEARCH ROUNDUP-Applied Materials, Humana, Waste Connections

Reuters
·
Feb 13

Bruker (BRKR) Q3 Loss Of US$62 Million Tests Bullish Margin Narratives

Simply Wall St.
·
Feb 13

Bruker Down Over 14%, on Pace for Largest Percent Decrease Since March 2020 -- Data Talk

Dow Jones
·
Feb 13

Bruker price target lowered to $50 from $55 at Jefferies

TIPRANKS
·
Feb 13

BUZZ-U.S. STOCKS ON THE MOVE-FedEx Corp, Lincoln National

Reuters
·
Feb 13

Stock Track | Bruker Plummets 14.52% Intraday After Q4 Earnings Miss Estimates

Stock Track
·
Feb 13

Stock Track | Bruker Plunges 6.69% in Pre-market After Q4 Profit Misses Estimates

Stock Track
·
Feb 12

BUZZ-U.S. STOCKS ON THE MOVE-PPG Industries, American Electric Power, West Pharmaceutical

Reuters
·
Feb 12

BUZZ-Bruker falls after Q4 profit misses estimates

Reuters
·
Feb 12

Shares of Bruker Down 1.7% Premarket After Q4 Profit Miss

THOMSON REUTERS
·
Feb 12

GUIDANCE: (BRKR) Bruker Expects Full Year 2026 Adjusted EPS Range $2.10 - $2.15, vs. FactSet Est of $2.14

MT Newswires Live
·
Feb 12

Bruker Q4 revenue beats estimates on biopharma market recovery

Reuters
·
Feb 12

Bruker reports FY25 GAAP diluted loss per share of USD -0.15, down from profit, and non-GAAP EPS of USD 1.83

Reuters
·
Feb 12